Biotechnology: Illumina, Inc. (NASDAQ:ILMN) Position of the day

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Illumina, Inc. (NASDAQ:ILMN) Biotechnology is valued at 23611.56. The dominant statistics will authorize the investment community to govern the size of Illumina, Inc. compared to the sales or total assets figures. Consequently, investors will be able to grasp the rudimentary determinant of asset distribution and all kinds of risk-return parameters for stocks together with the stock mutual funds. Nevertheless, it is a common misunderstanding that a greater share price directs towards a larger company where stock price might also twist the definite worth of the organization.

The current assessment for Illumina, Inc. NASDAQ:ILMN Biotechnology on its PE ratio displays a value of 53.65 with a Forward PE of 43.93. Illumina, Inc. Biotechnology has a PEG of 3.96 alongside a PS value of 9.96 and a PB value of 10.51.

Illumina, Inc. (NASDAQ:ILMN) Biotechnology shows a Dividend Yield of *TBA with a Payout Ratio of 0.00%. Illumina, Inc. Biotechnology holds an EPS of 2.99 that demonstrates an EPS growth this year at 30.50%. The growth for the next year comes down to 9.96%, and its growth for the last five years shows at 28.90%. Eventually, Illumina, Inc. Biotechnology exhibits an EPS value of 13.56% for the next five years. Sales growth in the quarter for Illumina, Inc. Biotechnology NASDAQ shows a value of 10.30% with Outstanding shares of 147.14.

Illumina, Inc. (NASDAQ:ILMN) Biotechnology has a Current Ratio of 3.6 with a Quick Ratio value of 3.1. The firm shows a 20-Day Simple Moving Average of 19.40% with a 200-Day Simple Moving Average of 7.20%. Its Day High was 7.20% and Day Low showed 34.43%. The 52-Week High shows -14.13% with a 52-Week Low of 34.43%.

Illumina, Inc. (NASDAQ:ILMN) Biotechnology has a current market price of 160.47 and the change is -1.29%. Its Target Price was fixed at 145.83 at an IPO Date of 7/28/2000. At present, the Gross Margin for Illumina, Inc. ILMN Biotechnology  is moving around at 69.90% alongside a Profit Margin of 18.70%. Performance week shows a value of 13.37%, and the Performance for the Month is valued at 27.92%. Volatility for the week appears to be 2.65% in conjunction with the Volatility for the month at 2.64%.

Disclaimer:  Outlined statistics and information communicated in the above editorial are merely a work of the authors. They do not ponder or echo the certified policy or position of any business stakeholders, financial specialists, or economic analysts. Specimens laid down on the editorial above are only cases with information collected from various sources. The authority will not be liable for anyone who makes stock portfolio or financial decisions as per the editorial, which is based only on limited and open source.

Share This Post

Post Comment